6533b859fe1ef96bd12b77ca

RESEARCH PRODUCT

Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

Alexander EnkJürgen KnopMichael StassenAndrea TuettenbergHelmut JonuleitEdgar Schmitt

subject

Immunoconjugateshuman regulatory T cellsT cellCTLA-4 expressionImmunologychemical and pharmacologic phenomenaCell CommunicationBiologyLymphocyte ActivationAbataceptMiceInterleukin 21Antigens CDT-Lymphocyte SubsetsCD4+CD25+ T cellsImmune TolerancemedicineAnimalsHumansImmunology and AllergyCytotoxic T cellCTLA-4 AntigenIL-2 receptorAntigen-presenting cellInterleukin 3toleranceCD28Receptors Interleukin-2hemic and immune systemsNatural killer T cellAntigens DifferentiationMolecular biologymedicine.anatomical_structureT cell inhibitionCD4 AntigensCytokinesLeukocyte Common AntigensOriginal Article

description

A subpopulation of peripheral human CD4(+)CD25(+) T cells that expresses CD45RO, histocompatibility leukocyte antigen DR, and intracellular cytotoxic T lymphocyte-associated antigen (CTLA) 4 does not expand after stimulation and markedly suppresses the expansion of conventional T cells in a contact-dependent manner. After activation, CD4(+)CD25(+) T cells express CTLA-4 on the surface detectable for several weeks. These cells show a G1/G0 cell cycle arrest and no production of interleukin (IL)-2, IL-4, or interferon (IFN)-gamma on either protein or mRNA levels. The anergic state of CD4(+)CD25(+) T cells is not reversible by the addition of anti-CD28, anti-CTLA-4, anti-transforming growth factor beta, or anti-IL-10 antibody. However, the refractory state of CD4(+)CD25(+) T cells was partially reversible by the addition of IL-2 or IL-4. These data demonstrate that human blood contains a resident T cell population with potent regulatory properties.

yearjournalcountryeditionlanguage
2001-06-08Journal of Experimental Medicine
https://doi.org/10.1084/jem.193.11.1285